What is the best country for stem cell therapy for Parkinson's Disease?
There is no best-country answer. Compare authorised protocol, sponsor, neurosurgical and movement-disorder expertise, product manufacturing, long-term monitoring and independent publication, not geography or testimonials.
The cost picture for Parkinson's Disease
A same-day intravenous product cannot be priced or evaluated as equivalent to a neurosurgical cell-replacement trial. Request an itemised statement for product, surgery or administration, imaging, immunosuppression where applicable, monitoring, travel and long-term follow-up. Preserve access to established neurological care.
Am I a candidate? → · Parkinson's Disease: full overview → · Parkinson's Disease cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Parkinson's Disease: cell-therapy evidence and registered trials
- How much does stem cell therapy for Parkinson's Disease cost? (2026)
- Parkinson's Disease stem cell therapy — your questions answered (2026)
- Parkinson's Disease: cell-therapy evidence by therapy class
- MSC vs exosomes for Parkinson's Disease: what the registries show